Immune globulin (LFB Biotechnologies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameImmune globulin (LFB Biotechnologies)
Drug Alias NameIqymuneClairygI10E
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesAutoimmune DiseasesMotor Neuron Disease +[4] 
Global Approved IndicationsImmunologic Deficiency SyndromesAutoimmune Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2010/01/01
Country/TerritoryTunisiaTurkeyItaly +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies Sas
China Registration ClassN/A

Develop Information

Active CompaniesLfb Biotechnologies Sas
Inactive CompaniesLaboratoire Français De Fractionnement Et De Biotechnologies
Active IndicationsImmunologic Deficiency SyndromesAutoimmune Diseases
Inactive IndicationsMotor Neuron DiseasePolyradiculoneuropathy, Chronic Inflammatory Demyelinating

Other Information

ATC CodeJ06BA02
Related LinksDrugBank